Tuesday, November 9, 2021

Safety concerns raised for neuroblastoma candidate drug

Scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.

from Top Health News -- ScienceDaily https://ift.tt/3bYpQjg
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Hidden blood molecules show surprising anti-aging power

Scientists have identified new anti-aging compounds produced by a little-studied blood bacterium. These indole metabolites were able to redu...